PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Blue Cross & Blue Shield of MississippiAll Plans · Coverage · Medical Policy · Oncology, RadiologyMedium impact

Radioembolization for Primary and Metastatic Tumors of the Liver

Effective date
Not stated in the notice
Identified
Jun 20, 2026

Summary

The policy considers yttrium-90 microsphere radioembolization medically necessary for primary hepatocellular carcinoma that is unresectable and limited to the liver, as a bridge to liver transplantation, and for primary intrahepatic cholangiocarcinoma in individuals with unresectable tumors. It also considers radioembolization medically necessary for hepatic metastases from neuroendocrine tumors with diffuse and symptomatic disease when systemic therapy has failed to control symptoms. It may be considered medically necessary for unresectable hepatic metastases from colorectal carcinoma, melanoma (ocular or cutaneous), or breast cancer that are both progressive and diffuse, in individuals with liver-dominant disease who are refractory to chemotherapy or are not candidates for chemotherapy or other systemic therapies. Radioembolization is investigational for all other hepatic metastases and for all other indications not described.

Get alerts when payers change rules like this one

We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.

Get Blue Cross & Blue Shield of Mississippi alertsPolicy Monitoring is free. No card required.

What to do

Action · 4 steps
01Billing team: Bill CPT 37243 and HCPCS S2095 only for radioembolization that meets the policy, since these codes are medically necessary only when the procedure is performed according to the policy section.
02Bill only when the diagnosis is one of the indications the policy covers, including ICD-10 codes C22.0, C22.1, C78.7 and C7B.02.
03Radioembolization should be reserved for individuals with Eastern Cooperative Oncology Group performance status 0 to 2, adequate liver function and reserve, Child-Pugh class A or B, and liver-dominant metastases, so document these characteristics.
04Keep documentation that supports medical necessity, because BCBSMS makes no payment for services that are not documented to be medically necessary.

Codes mentioned

37243S2095C22.0C22.1C78.7

Original notice

Radioembolization for Primary and Metastatic Tumors of the Liver
bcbsms.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account